NCT05450835 OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method Status RECRUITING Phase NA
NCT05447234 TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05447221 Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis System Status UNKNOWN Phase N/A
NCT05445401 Pre-rehabilitation in Neoadjuvant Patients With Gastric Cancer Status NOT_YET_RECRUITING Phase NA
NCT05442502 Safety and Efficacy of OGT Method Versus the Traditional Overlap Method Status COMPLETED Phase N/A
NCT05439993 Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT05438459 GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites Status RECRUITING Phase PHASE1/PHASE2
NCT05438420 Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05431244 Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC) Status WITHDRAWN Phase NA
NCT05430841 Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT Status COMPLETED Phase NA
NCT05427487 Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours Status RECRUITING Phase PHASE1
NCT05427214 Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy Status COMPLETED Phase NA
NCT05420259 Combined Exercise and Nutritional Intervention in GI Cancer Patients Status RECRUITING Phase NA
NCT05419362 GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer Status COMPLETED Phase PHASE2
NCT05415098 Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas Status UNKNOWN Phase PHASE1
NCT05412758 Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) Status RECRUITING Phase NA
NCT05411679 EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT05411133 Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients Status COMPLETED Phase PHASE1
NCT05410847 Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells Status UNKNOWN Phase PHASE2
NCT05410535 To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy Status COMPLETED Phase PHASE4